In Brief: DHEA study
This article was originally published in The Tan Sheet
Executive Summary
DHEA study: Double-blind clinical trial to study the effect of 100 mg/day doses of DHEA in Alzheimer's patients is being extended by two months and adding subjects with an additional grant from the sponsor, Neurocrine Biosciences. The study, originally scheduled to last six months, is being conducted by Owen Wolkowitz, MD at the University of California-San Francisco and should provide results by the end of 1997 ("The Tan Sheet" Aug. 12, p. 6)...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning